Changes in body composition after childhood cancer treatment: Impact on future health status-A review

Critical Reviews in Oncology/Hematology

Volumn 63, Issue 1, 2007, Pages 32-46

  Brouwer, C A J ^a   Gietema, J A ^b   Kamps, W A ^a   de Vries, E G E ^b   Postma, A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Body composition; Body mass index; Childhood cancer; Gene polymorphisms; Gonadal dysfunction; Growth hormone deficiency; Leptin; Obesity

Indexed keywords

CORTICOSTEROID; CYTOSTATIC AGENT;

BODY COMPOSITION; BODY MASS; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVOR; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; GROWTH HORMONE DEFICIENCY; HEALTH STATUS; HUMAN; LYMPHATIC LEUKEMIA; LYMPHOMA; OBESITY; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; POPULATION; REVIEW; SKULL IRRADIATION;

BODY COMPOSITION; BODY MASS INDEX; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CRANIAL IRRADIATION; GROWTH HORMONE; HEALTH STATUS; HUMANS; LEPTIN; LONGITUDINAL STUDIES; OBESITY; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 34249298374     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.01.007     Document Type: Review

References (72)

1. Ogden C.L., Flegal K.M., Carroll M.D., and Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
2. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
3. Fredriks A.M., Van Buuren S., Sing R.A., Wit J.M., and Verloove-Vanhorick S.P. Alarming prevalences of overweight and obesity for children of Turkish. Moroccan and Dutch origin in The Netherlands according to international standards. Acta Paediatr 94 (2005) 496-498
4. Yan L.L., Daviglus M.L., Liu K., et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 295 (2006) 190-198
5. Janssen I., Katzmarzyk P.T., Srinivasan S.R., et al. Utility of childhood BMI in the prediction of adulthood disease: comparison of national and international references. Obes Res 13 (2005) 1106-1115
6. Cheung Y.B., Machin D., Karlberg J., and Khoo K.S. A longitudinal study of pediatric body mass index values predicted health in middle age. J Clin Epidemiol 57 (2004) 1316-1322
7. Raitakari O.T., Juonala M., Kahonen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290 (2003) 2277-2283
8. Lo J., Dolan S.E., Kanter J.R., et al. Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 91 (2006) 1677-1682
9. Fernandes V.R., Polak J.F., Edvardsen T., et al. Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 47 (2006) 2420-2428
10. Dongen-Melman J.E., Hokken-Koelega A.C., Hahlen K., et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 38 (1995) 86-90
11. Gurney J.G., Ness K.K., Stovall M., et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab 88 (2003) 4731-4739
12. Lustig R.H., Post S.R., Srivannaboon K., et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88 (2003) 611-616
13. Muller H.L., Emser A., Faldum A., et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89 (2004) 3298-3305
14. Srinivasan S., Ogle G.D., Garnett S.P., et al. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89 (2004) 81-86
15. Harz K.J., Muller H.L., Waldeck E., Pudel V., and Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88 (2003) 5227-5231
16. Mayer E.I., Reuter M., Dopfer R.E., and Ranke M.B. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 53 (2000) 193-199
17. Link K., Moell C., Garwicz S., et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 89 (2004) 5003-5012
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
19. Talvensaari K.K., Lanning M., Tapanainen P., and Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 81 (1996) 3051-3055
20. Kourti M., Tragiannidis A., Makedou A., et al. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol 27 (2005) 499-501
21. Gurney J.G., Ness K.K., Sibley S.D., et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107 (2006) 1303-1312
22. Janssen I., Katzmarzyk P.T., and Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79 (2004) 379-384
23. Cole T.J., Bellizzi M.C., Flegal K.M., and Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320 (2000) 1240-1243
24. Meacham L.R., Gurney J.G., Mertens A.C., et al. Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer 103 (2005) 1730-1739
25. Mazess R.B., Barden H.S., Bisek J.P., and Hanson J. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51 (1990) 1106-1112
26. Boot A.M., Bouquet J., de Ridder M.A., Krenning E.P., and de Muinck Keizer-Schrama S.M. Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr 66 (1997) 232-238
27. Taylor R.W., Jones I.E., Williams S.M., and Goulding A. Body fat percentages measured by dual-energy X-ray absorptiometry corresponding to recently recommended body mass index cutoffs for overweight and obesity in children and adolescents aged 3-18 y. Am J Clin Nutr 76 (2002) 1416-1421
28. Warner J.T., Evans W.D., Webb D.K., and Gregory J.W. Pitfalls in the assessment of body composition in survivors of acute lymphoblastic leukaemia. Arch Dis Child 89 (2004) 64-68
29. Lukaski H.C., Johnson P.E., Bolonchuk W.W., and Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41 (1985) 810-817
30. Pecoraro P., Guida B., Caroli M., et al. Body mass index and skinfold thickness versus bioimpedance analysis: fat mass prediction in children. Acta Diabetol 40 Suppl. 1 (2003) S278-S281
31. Lewy V.D., Danadian K., and Arslanian S. Determination of body composition in African-American children: validation of bioelectrical impedence with dual energy X-ray absorptiometry. J Pediatr Endocrinol Metab 12 (1999) 443-448
32. Bulow B., Link K., Ahren B., Nilsson A.S., and Erfurth E.M. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Clin Endocrinol (Oxf) 61 (2004) 683-691
33. Follin C., Thilen U., Ahren B., and Erfurth E.M. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 91 (2006) 1872-1875
34. Murphy A.J., Wells J.C., Williams J.E., et al. Body composition in children in remission from acute lymphoblastic leukemia. Am J Clin Nutr 83 (2006) 70-74
35. Dempster P., and Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc 27 (1995) 1692-1697
36. Fredriks A.M., Van Buuren S., Fekkes M., Verloove-Vanhorick S.P., and Wit J.M. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice?. Eur J Pediatr 164 (2005) 216-222
37. Neville K.A., Cohn R.J., Steinbeck K.S., Johnston K., and Walker J.L. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab 91 (2006) 4401-4407
38. Warner J.T., Evans W.D., Webb D.K., and Gregory J.W. Body composition of long-term survivors of acute lymphoblastic leukaemia. Med Pediatr Oncol 38 (2002) 165-172
39. Davies J.H., Evans B.A., Jones E., et al. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxf) 60 (2004) 358-365
40. Dalton V.K., Rue M., Silverman L.B., et al. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J Clin Oncol 21 (2003) 2953-2960
41. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 21 (2003) 1359-1365
42. Didi M., Didcock E., Davies H.A., et al. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 127 (1995) 63-67
43. van Beek R.D., de Muinck Keizer-Schrama S.M., Hakvoort-Cammel F.G., et al. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 46 (2006) 88-93
44. Jarfelt M., Lannering B., Bosaeus I., Johannsson G., and Bjarnason R. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 153 (2005) 81-89
45. Sklar C.A., Mertens A.C., Walter A., et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 35 (2000) 91-95
46. Brennan B.M., Rahim A., Blum W.F., et al. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?. Clin Endocrinol (Oxf) 50 (1999) 163-169
47. Nysom K., Holm K., Michaelsen K.F., et al. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 84 (1999) 4591-4596
48. Nysom K., Holm K., Michaelsen K.F., et al. Degree of fatness after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 40 (2003) 239-243
49. van der Sluis I.M., van den Heuvel-Eibrink M.M., Hahlen K., Krenning E.P., and de Muinck Keizer-Schrama S.M. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35 (2000) 415-420
50. Reilly J.J., Brougham M., Montgomery C., et al. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 86 (2001) 3742-3745
51. Marinovic D., Dorgeret S., Lescoeur B., et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics 116 (2005) e102-e108
52. Warner J.T., Bell W., Webb D.K., and Gregory J.W. Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy. Arch Dis Child 76 (1997) 298-303
53. Whitaker R.C., Pepe M.S., Wright J.A., Seidel K.D., and Dietz W.H. Early adiposity rebound and the risk of adult obesity. Pediatrics 101 (1998) E5
54. Taylor R.W., Goulding A., Lewis-Barned N.J., and Williams S.M. Rate of fat gain is faster in girls undergoing early adiposity rebound. Obes Res 12 (2004) 1228-1230
55. Reilly J.J., Kelly A., Ness P., et al. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 86 (2001) 2775-2778
56. Birkebaek N.H., Fisker S., Clausen N., et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 30 (1998) 351-356
57. Murray R.D., Darzy K.H., Gleeson H.K., and Shalet S.M. GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 87 (2002) 129-135
58. Saarto T., Blomqvist C., Ehnholm C., Taskinen M.R., and Elomaa I. Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer. J Clin Endocrinol Metab 81 (1996) 4453-4457
59. Nuver J., Smit A.J., Wolffenbuttel B.H., et al. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 23 (2005) 3718-3725
60. Chemaitilly W., Mertens A.C., Mitby P., et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 91 (2006) 1723-1728
61. Sklar C.A., Mertens A.C., Mitby P., et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98 (2006) 890-896
62. Lantinga G.M., Simons A.H., Kamps W.A., and Postma A. Imminent ovarian failure in childhood cancer survivors. Eur J Cancer 42 (2006) 1415-1420
63. Relander T., Cavallin-Stahl E., Garwicz S., Olsson A.M., and Willen M. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 35 (2000) 52-63
64. Zaletel L.Z., Bratanic N., and Jereb B. Gonadal function in patients treated for leukemia in childhood. Leuk Lymphoma 45 (2004) 1797-1802
65. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
66. Stephens T.W., Basinski M., Bristow P.K., et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377 (1995) 530-532
67. Strosberg A.D., and Issad T. The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends Pharmacol Sci 20 (1999) 227-230
68. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130 (1999) 671-680
69. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
70. Wallace A.M., Tucker P., Williams D.M., Hughes I.A., and Ahmed S.F. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 58 (2003) 770-776
71. Ross J.A., Oeffinger K.C., Davies S.M., et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 22 (2004) 3558-3562
72. Herbert A., Gerry N.P., McQueen M.B., et al. A common genetic variant is associated with adult and childhood obesity. Science 312 (2006) 279-283